Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

February 18, 2019

Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T

Decipher Biosciences (formerly GenomeDx) has announced a research collaboration with Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, to apply genomic tumor profiling using the Decipher assay and GRID software to identify prostate cancer patients on active surveillance who may benefit most from treatment with sipuleucel-T.

Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T